Reducing HIV Transmission From Mum To Bub
Main Category: HIV / AIDSAlso Included In: Preventive Medicine
Article Date: 03 Aug 2008 - 0:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
3 (1 votes) |
| Article Opinions: | 1 posts |
National guidelines need to be developed and implemented to ensure an adequate uptake of interventions known to reduce the risk of perinatal HIV transmission, according to a research paper published in the latest issue of Medical Journal of Australia.
About 10 per cent of people living with HIV infection in Australia are women, many of whom are in their reproductive years.
Dr Michelle Giles, an Infectious Disease Specialist from the Alfred Hospital, and her co-authors said three key interventions have been shown to significantly reduce mother-to-child transmission of HIV:
Avoiding breastfeeding;
Antiretroviral (ARV) therapy administered antenatally, during labour and to the newborn child; and Elective caesarean section.
Dr Giles said the high uptake of preventative interventions in women known to have HIV infection who are having children in Australia is encouraging, but no cause for complacency.
"Most importantly, the unknown number of women with HIV infection who are giving birth undiagnosed emphasises the need to ensure all women have access to HIV testing and the potential benefits for their health and the health of their babies," she said.
In the retrospective analysis, 367 live births were reported from 291 Australian women with HIV infection between 1982 and 2005. During the same period, 80 mothers were diagnosed with AIDS and 50 mothers died.
Dr Giles said nearly all the women elected not to breastfeed and most used some ARV therapy. Only the choice of having a caesarean appeared to be rejected by the study group.
The researchers analysed the use of zidovudine: 24 per cent of the women did not receive the systemic antiviral drug and 43 per cent of those who did not take it received other ARVs.
"Possible explanations for inconsistent use of zidovudine include contraindications such as concurrent use of stavudine, changing understanding of the recommendations by clinicians over time or patient refusal," she said.
The Medical Journal of Australia is a publication of the Australian Medical Association.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/116940.php>
APA
http://www.medicalnewstoday.com/releases/116940.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Desired Dose And Time Of Anti Retroviral Drug To Newborns
posted by Dr.N.Sasidharan on 3 Aug 2008 at 9:35 amThe information is valuable.But we practising pediatricians would very well like to know the current recommendations regarding dose and time of administration of anti retroviral drug to the neonate.
DR,N.SASIDHARAN .NOORANAD ,KERALA INDIA
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



